134 related articles for article (PubMed ID: 21127929)
41. Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients.
Nabavi DG; Stockmann J; Schmid C; Schneider M; Hammel D; Scheld HH; Ringelstein EB
J Thorac Cardiovasc Surg; 2003 Jul; 126(1):160-7. PubMed ID: 12878951
[TBL] [Abstract][Full Text] [Related]
42. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
43. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653
[TBL] [Abstract][Full Text] [Related]
44. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
45. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
JAMA; 2019 Jun; 321(24):2414-2427. PubMed ID: 31237644
[TBL] [Abstract][Full Text] [Related]
46. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy.
Tzoran I; Brenner B; Sakharov G; Trujillo-Santos J; Lorenzo A; Madridano O; López-Sáez JB; Monreal M;
Eur J Intern Med; 2014 Nov; 25(9):821-5. PubMed ID: 25287697
[TBL] [Abstract][Full Text] [Related]
47. Safety and efficacy of catheter-based left atrial appendage closure in patients with contraindications for long-term anticoagulation.
Seidel A; Parwani AS; Krackhardt F; Huemer M; Attanasio P; Haverkamp W; Pieske B; Boldt LH
Minerva Cardioangiol; 2017 Dec; 65(6):545-552. PubMed ID: 28565887
[TBL] [Abstract][Full Text] [Related]
48. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A; De Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Cochrane Database Syst Rev; 2006 Jul; (3):CD001342. PubMed ID: 16855967
[TBL] [Abstract][Full Text] [Related]
49. Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy.
Nagata N; Niikura R; Aoki T; Shimbo T; Kishida Y; Sekine K; Tanaka S; Watanabe K; Sakurai T; Yokoi C; Akiyama J; Yanase M; Mizokami M; Uemura N
J Gastroenterol Hepatol; 2014 Oct; 29(10):1786-93. PubMed ID: 24720424
[TBL] [Abstract][Full Text] [Related]
50. Bleeding risk of combined oral anticoagulant and antiplatelet therapy in cardiovascular disease.
Verheugt FW
J Cardiovasc Risk; 1996 Apr; 3(2):229-32. PubMed ID: 8836868
[TBL] [Abstract][Full Text] [Related]
51. Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio.
Bhatia A; Juricek C; Sarswat N; Adatya S; Kim G; Sayer G; Ota T; Jeevanandam V; Uriel N
ASAIO J; 2018; 64(2):140-146. PubMed ID: 28661909
[TBL] [Abstract][Full Text] [Related]
52. Effects of aspirin or picotamide, an antithromboxane agent, in combination with low-intensity oral anticoagulation in patients with acute myocardial infarction: a controlled randomized pilot trial.
Vetrano A; Milani M; Corsini G
G Ital Cardiol; 1999 May; 29(5):524-8. PubMed ID: 10367219
[TBL] [Abstract][Full Text] [Related]
53. Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.
Jones L; Griffin S; Palmer S; Main C; Orton V; Sculpher M; Sudlow C; Henderson R; Hawkins N; Riemsma R
Health Technol Assess; 2004 Oct; 8(38):iii-iv, 1-196. PubMed ID: 15461876
[TBL] [Abstract][Full Text] [Related]
54. Postoperative bleeding complications after gastric cancer surgery in patients receiving anticoagulation and/or antiplatelet agents.
Mita K; Ito H; Murabayashi R; Sueyoshi K; Asakawa H; Nabetani M; Kamasako A; Koizumi K; Hayashi T
Ann Surg Oncol; 2012 Nov; 19(12):3745-52. PubMed ID: 22805868
[TBL] [Abstract][Full Text] [Related]
55. Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device - the role of anticoagulation.
van den Bergh WM; Lansink-Hartgring AO; van Duijn AL; Engström AE; Lahpor JR; Slooter AJ
J Cardiothorac Surg; 2015 Oct; 10():128. PubMed ID: 26471178
[TBL] [Abstract][Full Text] [Related]
56. Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol Versus Standard Dual Antiplatelet in Patients With High Posttreatment Platelet Reactivity: Results of the CREATIVE Trial.
Tang YD; Wang W; Yang M; Zhang K; Chen J; Qiao S; Yan H; Wu Y; Huang X; Xu B; Gao R; Yang Y;
Circulation; 2018 May; 137(21):2231-2245. PubMed ID: 29420189
[TBL] [Abstract][Full Text] [Related]
57. Close antiplatelet therapy monitoring and adjustment based upon thrombelastography may reduce late-onset bleeding in HeartMate II recipients.
Karimi A; Beaver TM; Hess PJ; Martin TD; Staples ED; Schofield RS; Hill JA; Aranda JM; Klodell CT
Interact Cardiovasc Thorac Surg; 2014 Apr; 18(4):457-65. PubMed ID: 24421208
[TBL] [Abstract][Full Text] [Related]
58. Antiplatelet therapy in anticoagulated patients requiring coronary intervention.
Arab D; Lewis B; Cho L; Steen L; Joyal D; Leya F
J Invasive Cardiol; 2005 Oct; 17(10):549-54. PubMed ID: 16204751
[TBL] [Abstract][Full Text] [Related]
59. Antithrombotic and anticoagulant therapy for atrial fibrillation.
Dzeshka MS; Lip GY
Cardiol Clin; 2014 Nov; 32(4):585-99. PubMed ID: 25443239
[TBL] [Abstract][Full Text] [Related]
60. First clinical experience with the Incor left ventricular assist device.
Schmid C; Tjan TD; Etz C; Schmidt C; Wenzelburger F; Wilhelm M; Rothenburger M; Drees G; Scheld HH
J Heart Lung Transplant; 2005 Sep; 24(9):1188-94. PubMed ID: 16143232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
